Invesaro

Stocks JBTM Financial statements

Financial statements

JBT MAREL Corp financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data JBT MAREL Corp files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue1,3511,6351,9201,9461,7281,8681,5901,6641,7163,798
Cost of revenue8049611,3821,0611,0791,0902,464
Gross profit1581902342642242202555866271,335
Research and development23.628.726.928.529.3222320.520.9116
Selling, general and administrative267325347396359351390410
Operating expenses64.357.6
Operating income101144144188163126133165118189
Interest expense9.413.613.918.813.911.216.324.319.4114
Interest income1.6
Pre-tax income9413212916714612012015395.3-62.4
Income tax2650.124.637.636.72716.223.510.7-13.1
Income from continuing operations6882.110412910992.510412984.6-49.7
Net income67.680.510412910911913758385.4-50.5
EBITDA140196202254235202214256208456
EPS, basic2.302.563.264.043.403.724.2918.212.67-0.98
EPS, diluted2.272.533.234.023.393.714.2818.132.65-0.98
Shares, basic (weighted)29.431.431.931.9323232323252
Shares, diluted (weighted)29.831.932.23232.132.132.132.132.252
Dividend per share0.400.400.400.400.400.400.400.400.400.40

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents33.2344339.547.578.871.74831,228168
Short-term investments0
Receivables261226253289236239201214240443
Inventory140190206245197229264239233644
Other current assets51.74845.760.466.977.375.789.166.7190
Total current assets4855896197086167199271,1001,8631,583
Property, plant and equipment210233240266268268245248234793
Lease right-of-use assets30.72733.537.537.332.375.1
Goodwill2403023215295446477707807693,428
Intangible assets1862172143262993434303893412,122
Other non-current assets31.738.14986.378.8128183194207265
Total assets1,1871,3911,4431,9151,8062,1412,6412,7103,4148,191
Accounts payable136157191199141186171135131262
Accrued liabilities42.9
Short-term debt7.110.50.50.92.400.600412
Total current liabilities3934414854754585506244845361,622
Long-term debt4923733876985236749776461,2521,470
Lease liabilities22.319.725.229.127.221.756.2
Other non-current liabilities36.849.540.798.794.710991.266.140.6252
Total liabilities1,0089509861,3451,1691,3911,7361,2221,8703,727
Total debt4923733876985236749776461,2521,470
Paid-in capital77.22522462422302142212282342,717
Retained earnings2673344175336287338941,4641,5361,465
Treasury stock-7.2-4-19.3-12.6-10-5.3-7.1-1.80
Other comprehensive income-157-140-187-193-220-197-204-196-225281
Shareholders' equity1804424575706727879051,4891,5444,464
Total equity1804424575706377519051,4891,5444,464
Total liabilities and equity1,1871,3911,4431,9151,8062,1412,6412,7103,4148,191
Shares outstanding29.231.631.531.731.731.831.831.831.852

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income67.680.510412910911913758385.4-50.5
Depreciation and amortization38.551.757.765.671.876.881.191.389.4266
Stock-based compensation9.999.79.41.95.58.911.414.723.2
Deferred income tax-0.118.34.819.89.8-3.2-19.1-21.6-25.8-79.6
Change in receivables-29-35.8-7.2-18.862.5-29.1-28.2-21.6-59.213.7
Change in inventory-2.9-23.7-7.5-5.744-36.9-47.326.93.7-53.9
Change in payables16.18.535.8-3.7-613229.1-32.10.6-16.3
Cash from operations67.410515411025222614274.2233342
Capital expenditures-37.1-37.9-39.8-37.9-34.3-51.7-84.6-55.1-37.9-104
Acquisitions-232-104-57.5-366-4.5-225-330-0.10-1,746
Purchases of investments00-12500
Sales and maturities of investments0012500
Cash from investing-267-140-94.4-402-37.3-273-416729-41.3-1,843
Debt issued15000
Debt repaid-2-1.50000-6.8
Stock issued018400-2,498
Share buybacks-4.3-5-20000-7.7-5.100
Dividends paid-11.8-12.7-13.1-12.7-12.8-12.8-13.1-12.8-13.1-20.9
Cash from financing19534.7-48.3288-20780.8271-354562458
Exchange rate effect0.51.4-2.20.50.7-2.3-2.5
Net change in cash-40.89-3.5831.3-5.7410745-1,042
Free cash flow30.366.711472.321817457.719.1195238
Interest paid10.413.11621.914.28.81320.77.599.5
Income taxes paid25.82419.829.236.436.427.947.133.268.7

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $110.09 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin35.6%Gross profit / revenue.
Operating margin7.3%Operating income / revenue.
Pre-tax margin6.1%Pre-tax income / revenue.
Net margin4.9%Net income / revenue.
FCF margin7.9%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin10.9%Cash from operations / revenue.
Effective tax rate19.7%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)4.3%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)2.4%Net income / average total assets.
Return on invested capital (ROIC)3.8%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue0.8%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue2.9%Capital expenditures / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y121.3%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y33.7%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y17.1%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y113.0%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y73.6%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y43.0%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y60.0%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y12.6%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y3.0%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y119.2%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y28.7%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y14.2%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-159.1%Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y-137.0%EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y46.9%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y33.9%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y6.3%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y22.3%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y60.4%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y1.8%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y0.0%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y0.0%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y0.0%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y189.1%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y70.2%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y46.0%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y139.9%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y45.8%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y35.3%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y61.5%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y17.4%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y10.1%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.24xCurrent assets / current liabilities.
Quick ratio0.43x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.09x(Cash + short-term investments) / current liabilities.
Debt / equity0.37xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets20.9%Total debt / total assets.
Liabilities / assets44.1%Total liabilities / total assets.
Net debt$1.56BTotal debt - cash - short-term investments. Negative means more cash than debt.
Working capital$311.0MCurrent assets - current liabilities.
Goodwill and intangibles / assets66.9%(Goodwill + intangible assets) / total assets.
Tangible book value-$885.0MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.49xRevenue / average total assets.
Fixed asset turnover5.08xRevenue / average property, plant and equipment.
Inventory turnover3.61xCost of revenue / average inventory.
Days inventory101 days365 x average inventory / cost of revenue.
Receivables turnover8.86xRevenue / average receivables.
Days sales outstanding41 days365 x average receivables / revenue.
Days payables43 days365 x average accounts payable / cost of revenue.
Cash conversion cycle99 daysDays inventory + days sales outstanding - days payables.
FCF conversion161.3%Free cash flow / net income, when net income is positive.
Capex / operating cash flow27.1%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$3.69Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$75.21Revenue / diluted weighted shares.
FCF per share$5.95Free cash flow / diluted weighted shares.
Operating cash flow per share$8.16Cash from operations / diluted weighted shares.
Book value per share$86.21Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$17.06Tangible book value / shares outstanding.
Cash per share$2.16(Cash + short-term investments) / shares outstanding.
Payout ratio10.9%Dividends paid / net income, when net income is positive.
Dividends / FCF6.7%Dividends paid / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$5.71BShare price x shares outstanding.
Enterprise value$7.27BMarket cap + total debt - cash - short-term investments.
P/E29.7xMarket cap / net income. Only when net income is positive.
P/S1.45xMarket cap / revenue.
P/B1.28xMarket cap / shareholders' equity. Only when equity is positive.
P/FCF18.4xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF13.4xMarket cap / cash from operations, when positive.
EV/Sales1.85xEnterprise value / revenue.
EV/EBIT25.2xEnterprise value / operating income, when both are positive.
EV/FCF23.4xEnterprise value / free cash flow, when both are positive.
FCF yield5.4%Free cash flow / market cap.
Earnings yield3.4%Net income / market cap (the inverse of P/E).
Dividend yield0.4%Dividends paid over the period / market cap.
Shareholder yield0.4%(Dividends paid + share buybacks) / market cap.
What was JBT MAREL Corp's revenue in fiscal 2025?

JBT MAREL Corp reported revenue of $3.80B for fiscal 2025, 121.3% higher than the year before.

Was JBT MAREL Corp profitable in fiscal 2025?

No. It reported a net loss of $50.5M.

How much free cash flow did JBT MAREL Corp generate in fiscal 2025?

Cash from operations of $341.7M minus capital expenditures of $103.6M left free cash flow of $238.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to JBT MAREL Corp